Insights, Life Changes and Lifestyle Changes Reported by Individuals Consuming Ayahuasca in Naturalistic Settings: Nature, Frequency and Associations with Mental Health and Wellbeing
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design
2.2. Insights, Life and Lifestyle Change Variables
2.3. Ayahuasca Drinking Variables
2.4. Mental Health and Wellbeing Variables
Analysis Plan
2.5. Statistical Analyses
3. Results
3.1. Sample Characteristics
3.2. Frequency and Nature of Insights and Life Changes
3.2.1. Insights
- New understandings of childhood events or situations;
- Understanding patterns and dynamics in your intimate relationships;
- New understandings of other family/personal relationships;
- New understanding of your own personality;
- Realisations about ethics or morals and your own conduct;
- Revelations about the purpose or direction of your life;
- Profound intellectual or philosophical ideas or insights;
- New understandings of your body, how it functions and how to take care of it or heal disease;
- A sense that everything and all events, even when seemingly unrelated, are somehow connected;
- An increased sense of connection to the natural world and feeling of kinship with plants and animals;
- An increased awareness and concern for social or environmental issues;
- A connection with plant spirits, guides or intelligence that can support your life;
- A sense of sacredness, a higher power or divine in the world;
- A sense that you are particularly close to, or have been chosen by, spirit/the divine/god in some way;
- A new understanding or acceptance of death and dying.
3.2.2. Life Changes after Drinking Ayahuasca
3.2.3. Lifestyle Changes after Drinking Ayahuasca
3.3. Correlations between Insights and Life and Lifestyle Changes
3.3.1. Multivariate Analysis
Dimensions Analysis—Insights, Life Changes and Lifestyle Changes
Multivariate Models—Predictors of Insights, Lifestyle and Life Changes
3.3.2. Association with Perceived Wellbeing Growth and Current Mental Health Status
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Palhano-Fontes, F.; Alchieri, J.; Oliveira, J.; Soares, B.; Hallak, J.C.; Galvao-Coelho, N.; de Araujo, D. The Therapeutic Potentials of Ayahuasca in the Treatment of Depression. In The Therapeutic Use of Ayahuasca; Labate, B.C., Cavnar, C., Eds.; Springer: Berlin/Heidelberg, Germany, 2014; pp. 23–39. [Google Scholar]
- James, E.; Keppler, J.; Robertshaw, T.L.; Sessa, B. N,N-dimethyltryptamine and Amazonian ayahuasca plant medicine. Hum. Psychopharmacol. 2022, 37, e2835. [Google Scholar] [CrossRef]
- Tupper, K.W. The globalization of ayahuasca: Harm reduction or benefit maximization? Int. J. Drug Policy 2008, 19, 297–303. [Google Scholar] [CrossRef] [PubMed]
- Grob, C.S.; McKenna, D.J.; Callaway, J.C.; Brito, G.S.; Neves, E.S.; Oberlaender, G.; Saide, O.L.; Labigalini, E.; Tacla, C.; Miranda, C.T.; et al. Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil. J. Nerv. Ment. Dis. 1996, 184, 86–94. [Google Scholar] [CrossRef] [PubMed]
- Fotiou, E. The Globalization of Ayahuasca Shamanism and the Erasure of Indigenous Shamanism. Anthropol. Conscious. 2016, 27, 151. [Google Scholar] [CrossRef]
- Kavenská, V.; Simonová, H. Ayahuasca Tourism: Participants in Shamanic Rituals and their Personality Styles, Motivation, Benefits and Risks. J. Psychoact. Drugs 2015, 47, 351–359. [Google Scholar] [CrossRef] [PubMed]
- Trichter, S. Ayahuasca beyond the amazon: The benefits and risks of a spreading tradition. J. Transpers. Psychol. 2010, 42, 131–148. [Google Scholar]
- Gearin, A.K. ‘Whatever you want to believe’ kaleidoscopic individualism and ayahuasca healing in Australia. Aust. J. Anthropol. 2015, 26, 442–455. [Google Scholar] [CrossRef]
- Perkins, D.; Schubert, V.; Simonová, H.; Tófoli, L.F.; Bouso, J.C.; Horák, M.; Galvão-Coelho, N.L.; Sarris, J. Influence of Context and Setting on the Mental Health and Wellbeing Outcomes of Ayahuasca Drinkers: Results of a Large International Survey. Front. Pharmacol. 2021, 12, 623979. [Google Scholar] [CrossRef]
- Perkins, D.; Ruffell, S.G.D.; Day, K.; Pinzon Rubiano, D.; Sarris, J. Psychotherapeutic and neurobiological processes associated with ayahuasca: A proposed model and implications for therapeutic use. Front. Neurosci. 2023, 16, 879221. [Google Scholar] [CrossRef]
- Rodrigues, L.S.; Rossi, G.N.; Rocha, J.M.; Osório, F.L.; Bouso, J.C.; Hallak, J.E.C.; dos Santos, R.G. Effects of ayahuasca and its alkaloids on substance use disorders: An updated (2016–2020) systematic review of preclinical and human studies. Eur. Arch. Psychiatry Clin. Neurosci. 2021, 272, 541–556. [Google Scholar] [CrossRef]
- Dos Santos, R.G.; Bouso, J.C.; Hallak, J.E.C. Ayahuasca, dimethyltryptamine, and psychosis: A systematic review of human studies. Ther. Adv. Psychopharmacol. 2017, 7, 141–157. [Google Scholar] [CrossRef] [PubMed]
- Jiménez-Garrido, D.F.; Gómez-Sousa, M.; Ona, G.; Dos Santos, R.G.; Hallak, J.E.C.; Alcázar-Córcoles, M.Á.; Bouso, J.C. Effects of ayahuasca on mental health and quality of life in naïve users: A longitudinal and cross-sectional study combination. Sci. Rep. 2020, 10, 4075. [Google Scholar] [CrossRef] [PubMed]
- Giovannetti, C.; Garcia Arce, S.; Rush, B.; Mendive, F. Pilot Evaluation of a Residential Drug Addiction Treatment Combining Traditional Amazonian Medicine, Ayahuasca and Psychotherapy on Depression and Anxiety. J. Psychoact. Drugs 2020, 52, 472–481. [Google Scholar] [CrossRef]
- Barbosa, P.C.R.; Cazorla, I.M.; Giglio, J.S.; Strassman, R. A Six-Month Prospective Evaluation of Personality Traits, Psychiatric Symptoms and Quality of Life in Ayahuasca-Naïve Subjects. J. Psychoact. Drugs 2009, 41, 205–212. [Google Scholar] [CrossRef] [PubMed]
- Uthaug, M.V.; van Oorsouw, K.; Kuypers, K.P.C.; van Boxtel, M.; Broers, N.J.; Mason, N.L.; Toennes, S.W.; Riba, J.; Ramaekers, J.G. Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution. Psychopharmacology 2018, 235, 2979–2989. [Google Scholar] [CrossRef] [PubMed]
- Perkins, D.; Pagni, B.A.; Sarris, J.; Barbosa, P.C.R.; Chenhall, R. Changes in mental health, wellbeing and personality following ayahuasca consumption: Results of a naturalistic longitudinal study. Front. Pharmacol. 2022, 13, 884703. [Google Scholar] [CrossRef]
- Mendes Rocha, J.; Rossi, G.N.; Osorio, F.L.; Bouso Saiz, J.C.; Silveira, G.O.; Yonamine, M.; Crevelin, E.J.; Queiroz, M.E.; Cecilio Hallak, J.E.; Dos Santos, R.G. Effects of Ayahuasca on Personality: Results of Two Randomized, Placebo-Controlled Trials in Healthy Volunteers. Front. Psychiatry 2021, 12, 688439. [Google Scholar] [CrossRef]
- Kaasik, H.; Kreegipuu, K. Ayahuasca Users in Estonia: Ceremonial Practices, Subjective Long-Term Effects, Mental Health, and Quality of Life. J. Psychoact. Drugs 2020, 52, 255–263. [Google Scholar] [CrossRef]
- Bouso, J.C.; González, D.; Fondevila, S.; Cutchet, M.; Fernández, X.; Ribeiro Barbosa, P.C.; Alcázar-Córcoles, M.Á.; Araújo, W.S.; Barbanoj, M.J.; Fábregas, J.M.; et al. Personality, Psychopathology, Life Attitudes and Neuropsychological Performance among Ritual Users of Ayahuasca: A Longitudinal Study. PLoS ONE 2012, 7, e42421. [Google Scholar] [CrossRef]
- Bouso, J.C.; Palhano-Fontes, F.; Rodríguez-Fornells, A.; Ribeiro, S.; Sanches, R.; Crippa, J.A.S.; Hallak, J.E.C.; Araujo, D.B.; Riba, J. Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans. Eur. Neuropsychopharmacol. 2015, 25, 483–492. [Google Scholar] [CrossRef]
- Bouso, J.C.; Andión, Ó.; Sarris, J.J.; Scheidegger, M.; Tófoli, L.F.; Opaleye, E.S.; Schubert, V.; Perkins, D. Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey. PLoS Global Public Health 2022, 2, e0000438. [Google Scholar] [CrossRef] [PubMed]
- Ly, C.; Greb, A.C.; Cameron, L.P.; Wong, J.M.; Barragan, E.V.; Wilson, P.C.; Burbach, K.F.; Soltanzadeh Zarandi, S.; Sood, A.; Paddy, M.R.; et al. Psychedelics Promote Structural and Functional Neural Plasticity. Cell Rep. 2018, 23, 3170–3182. [Google Scholar] [CrossRef] [PubMed]
- Palhano-Fontes, F.; Andrade, K.C.; Tofoli, L.F.; Santos, A.C.; Crippa, J.A.S.; Hallak, J.E.C.; Ribeiro, S.; de Araujo, D.B. The Psychedelic State Induced by Ayahuasca Modulates the Activity and Connectivity of the Default Mode Network. PLoS ONE 2015, 10, e0118143. [Google Scholar] [CrossRef]
- Dos Santos, R.G.; Osório, F.L.; Crippa, J.A.S.; Riba, J.; Zuardi, A.W.; Hallak, J.E.C. Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): A systematic review of clinical trials published in the last 25 years: Antidepressive effects of ayahuasca, psilocybin and LSD. Ther. Adv. Psychopharmacol. 2016, 6, 193–213. [Google Scholar] [CrossRef] [PubMed]
- Muttoni, S.; Ardissino, M.; John, C. Classical psychedelics for the treatment of depression and anxiety: A systematic review. J. Affect. Disord. 2019, 258, 11–24. [Google Scholar] [CrossRef] [PubMed]
- Sanches, R.F.; de Lima Osório, F.; dos Santos, R.G.; Macedo, L.R.H.; Maia-de-Oliveira, J.P.; Wichert-Ana, L.; de Araujo, D.B.; Riba, J.; Crippa, J.A.S.; Hallak, J.E.C. Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study. J. Clin. Psychopharmacol. 2016, 36, 77–81. [Google Scholar] [CrossRef]
- Wang, X.; Wu, Q.; Egan, L.; Gu, X.; Liu, P.; Gu, H.; Yang, Y.; Luo, J.; Wu, Y.; Gao, Z.; et al. Anterior insular cortex plays a critical role in interoceptive attention. eLife 2019, 8, 42265. [Google Scholar] [CrossRef]
- Riba, J.; Romero, S.; Grasa, E.; Mena, E.; Carrió, I.; Barbanoj, M. Increased frontal and paralimbic activation following ayahuasca, the pan-amazonian inebriant. Psychopharmacology 2006, 186, 93–98. [Google Scholar] [CrossRef]
- McKenna, D.; Riba, J. New World Tryptamine Hallucinogens and the Neuroscience of Ayahuasca; Springer: Berlin/Heidelberg, Germany, 2015; pp. 1–27. [Google Scholar]
- Carhart-Harris, R.L.; Friston, K.J. REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics. Pharmacol. Rev. 2019, 71, 316–344. [Google Scholar] [CrossRef]
- Walsh, R.; Vaughan, F. On transpersonal definitions. J. Transpers. Psychol. 1993, 25, 199–207. [Google Scholar]
- Perkins, D.; Opaleye, E.; Simonova, H.; Bouso, J.C.; Tófoli, L.F.; Galvão-Coelho, N.L.; Schubert, V.; Sarris, J. Associations between ayahuasca consumption in naturalistic settings and current alcohol and drug use: Results of a large international cross-sectional survey. Drug Alcohol Rev. 2021, 41, 265–274. [Google Scholar] [CrossRef] [PubMed]
- Russ, S.L.; Carhart-Harris, R.L.; Maruyama, G.; Elliott, M.S. States and traits related to the quality and consequences of psychedelic experiences. Psychol. Conscious. Theory Res. Pract. 2019, 6, 1–21. [Google Scholar] [CrossRef]
- Breeksema, J.J.; Niemeijer, A.R.; Krediet, E.; Vermetten, E.; Schoevers, R.A. Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies. CNS Drugs 2020, 34, 925–946. [Google Scholar] [CrossRef] [PubMed]
- Loizaga-Velder, A.; Verres, R. Therapeutic effects of ritual ayahuasca use in the treatment of substance dependence–qualitative results. J. Psychoact. Drugs 2014, 46, 63–72. [Google Scholar] [CrossRef]
- Wolff, T.J.; Ruffell, S.; Netzband, N.; Passie, T. A phenomenology of subjectively relevant experiences induced by ayahuasca in Upper Amazon vegetalismo tourism. J. Psychedelic Stud. 2019, 3, 295–307. [Google Scholar] [CrossRef]
- Shanon, B. The Antipodes of the Mind: Charting the Phenomenology of the Ayahuasca Experience; Oxford University Press: Oxford, UK, 2002. [Google Scholar]
- Schmid, J.T. The Myth of Ayahuasca-Chapter 5. In Rituals Types, Efficacy and Myths; Smet, E.D., Bauwens, F., Eds.; Nove Science: New York, NY, USA, 2012. [Google Scholar]
- Shanon, B. The epistemics of ayahuasca visions. Phenomenol. Cogn. Sci. 2010, 9, 263–280. [Google Scholar] [CrossRef]
- Franquesa, A.; Sainz-Cort, A.; Gandy, S.; Soler, J.; Alcázar-Córcoles, M.Á.; Bouso, J.C. Psychological variables implied in the therapeutic effect of ayahuasca: A contextual approach. Psychiatry Res. 2018, 264, 334–339. [Google Scholar] [CrossRef]
- Loizaga-Velder, A. A Psychotherapeutic View on the Therapeutic Effects of Ritual Ayahuasca Use in the Treatment of Addiction. MAPS Bull. 2013, 23, 36–40. [Google Scholar]
- Maia, L.O.; Daldegan-Bueno, D.; Tófoli, L.F. The ritual use of ayahuasca during treatment of severe physical illnesses: A qualitative study. Psychoact. Drugs 2020, 53, 272–282. [Google Scholar] [CrossRef]
- Wolff, T.J. The Touristic Use of Ayahuasca in Peru Expectations, Experiences, Meanings and Subjective Effects; Springer: Bremen, Germany, 2020. [Google Scholar]
- Kohek, M.; Ona, G.; van Elk, M.; Dos Santos, R.G.; Hallak, J.E.C.; Alcazar-Corcoles, M.A.; Bouso, J.C. Ayahuasca and Public Health II: Health Status in a Large Sample of Ayahuasca-Ceremony Participants in the Netherlands. J. Psychoact. Drugs 2022, 55, 247–258. [Google Scholar] [CrossRef]
- Glausser, W. Psychedelic Drugs and Atheism: Debunking the Myths. Religions 2021, 12, 614. [Google Scholar] [CrossRef]
- Johnson, M.W.; Yaden, D.B. There’s No Good Evidence That Psychedelics Can Change Your Politics or Religion: The BALANCE of data Don’t Support the Idea, and Claims Otherwise Could Lead to Alarmism. Scientific American, 5 November 2020. [Google Scholar]
- Garcia-Romeu, A.; Davis, A.K.; Erowid, F.; Erowid, E.; Griffiths, R.R.; Johnson, M.W. Cessation and reduction in alcohol consumption and misuse after psychedelic use. J. Psychopharmacol. 2019, 33, 1088–1101. [Google Scholar] [CrossRef] [PubMed]
- Noorani, T.; Garcia-Romeu, A.; Swift, T.C.; Griffiths, R.R.; Johnson, M.W. Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts. J. Psychopharmacol. 2018, 32, 756–769. [Google Scholar] [CrossRef] [PubMed]
- Davis, A.K.; Barrett, F.S.; Griffiths, R.R. Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety. J. Context. Behav. Sci. 2020, 15, 39–45. [Google Scholar] [CrossRef]
- Williams, M.T.; Davis, A.K.; Xin, Y.; Sepeda, N.D.; Grigas, P.C.; Sinnott, S.; Haeny, A.M. People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences. Drugs 2021, 28, 215–226. [Google Scholar] [CrossRef]
- Gonzalez, D.; Cantillo, J.; Perez, I.; Carvalho, M.; Aronovich, A.; Farre, M.; Feilding, A.; Obiols, J.E.; Bouso, J.C. The Shipibo Ceremonial Use of Ayahuasca to Promote Well-Being: An Observational Study. Front. Pharmacol. 2021, 12, 623923. [Google Scholar] [CrossRef]
- Jennissen, S.; Huber, J.; Ehrenthal, J.C.; Schauenburg, H.; Dinger, U. Association Between Insight and Outcome of Psychotherapy: Systematic Review and Meta-Analysis. Am. J. Psychiatry 2018, 175, 961–969. [Google Scholar] [CrossRef]
- Peill, J.M.; Trinci, K.E.; Kettner, H.; Mertens, L.J.; Roseman, L.; Timmermann, C.; Rosas, F.E.; Lyons, T.; Carhart-Harris, R.L. Validation of the Psychological Insight Scale: A new scale to assess psychological insight following a psychedelic experience. J. Psychopharmacol. 2022, 36, 31–45. [Google Scholar] [CrossRef]
- Kounios, J.; Beeman, M. The cognitive neuroscience of insight. Annu. Rev. Psychol. 2014, 65, 71–93. [Google Scholar] [CrossRef]
- Osuna-Mascaro, A.J.; Auersperg, A.M.I. Current Understanding of the “Insight” Phenomenon Across Disciplines. Front. Psychol. 2021, 12, 791398. [Google Scholar] [CrossRef]
- Griffiths, R.R.; Johnson, M.W.; Richards, W.A.; Richards, B.D.; McCann, U.; Jesse, R. Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects. Psychopharmacology 2011, 218, 649–665. [Google Scholar] [CrossRef]
- Francis, L.J.L.S.H. A Short Index of Mystical Orientation (SIMO): A Study Among Roman Catholic Priests. Pastor. Psychol. 2004, 53, 49–51. [Google Scholar] [CrossRef]
- Kroenke, K.; Spitzer, R.L.; Williams, J.B.; Löwe, B. An ultra-brief screening scale for anxiety and depression: The PHQ-4. Psychosomatics 2009, 50, 613–621. [Google Scholar] [CrossRef]
- Joseph, S.; Maltby, J.; Wood, A.M.; Stockton, H.; Hunt, N.; Regel, S. The Psychological Well-Being—Post-Traumatic Changes Questionnaire (PWB-PTCQ): Reliability and validity. Psychol. Trauma: Theory Res. Pract. Policy 2012, 4, 420–428. [Google Scholar] [CrossRef]
- Maruish, M.E. User’s Manual for the SF-12v2 Health Survey, 3rd ed.; Quality Metric Incorporated: Lincoln, RI, USA, 2012. [Google Scholar]
- Kessler, R.C.; Andrews, G.; Colpe, L.J.; Hiripi, E.; Mroczek, D.K.; Normand, S.L.; Walters, E.E.; Zaslavsky, A.M. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol. Med. 2002, 32, 959–976. [Google Scholar] [CrossRef] [PubMed]
- Paul, H.B. HIREG: Stata Module for Hierarchial Regression, S432904; Boston College Department of Economics: Boston, MA, USA, 2003. [Google Scholar]
- Studerus, E.; Vizeli, P.; Harder, S.; Ley, L.; Liechti, M.E. Prediction of MDMA response in healthy humans: A pooled analysis of placebo-controlled studies. J. Psychopharmacol. 2021, 35, 556–565. [Google Scholar] [CrossRef]
- Yarborough, B.J.H.; Stumbo, S.P.; Rosales, A.G.; Ahmedani, B.K.; Boggs, J.M.; Daida, Y.G.; Negriff, S.; Rossom, R.C.; Simon, G.; Perrin, N.A. Opioid-related variables did not improve suicide risk prediction models in samples with mental health diagnoses. J. Affect. Disord. Rep. 2022, 8, 100346. [Google Scholar] [CrossRef] [PubMed]
- Tibshirani, R. The lasso method for variable selection in the Cox model. Stat. Med. 1997, 16, 385–395. [Google Scholar] [CrossRef]
- Steyerberg, E.W.; Eijkemans, M.J.C.; Habbema, J.D.F. Application of Shrinkage Techniques in Logistic Regression Analysis: A Case Study. Stat. Neerl. 2001, 55, 76–88. [Google Scholar] [CrossRef]
- Foubister, C.; van Sluijs, E.M.F.; Vignoles, A.; Wilkinson, P.; Wilson, E.C.F.; Croxson, C.H.D.; Brown, H.E.; Corder, K. The school policy, social, and physical environment and change in adolescent physical activity: An exploratory analysis using the LASSO. PLoS ONE 2021, 16, e0249328. [Google Scholar] [CrossRef]
- Cronbach, L.J. Coefficient alpha and the internal structure of tests. Psychometrika 1951, 16, 297–334. [Google Scholar] [CrossRef]
- Roseman, L.; Haijen, E.; Idialu-Ikato, K.; Kaelen, M.; Watts, R.; Carhart-Harris, R. Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory. J. Psychopharmacol. 2019, 33, 1076–1087. [Google Scholar] [CrossRef]
- Michael, P.; Luke, D.; Robinson, O. An Encounter With the Other: A Thematic and Content Analysis of DMT Experiences From a Naturalistic Field Study. Front. Psychol. 2021, 12, 720717. [Google Scholar] [CrossRef]
- Daldegan-Bueno, D.; Maia, L.O.; Massarentti, C.M.; Tofoli, L.F. Ayahuasca and tobacco smoking cessation: Results from an online survey in Brazil. Psychopharmacology 2022, 239, 1767–1782. [Google Scholar] [CrossRef]
- Ona, G.; Kohek, M.; Massaguer, T.; Gomariz, A.; Jimenez, D.F.; Dos Santos, R.G.; Hallak, J.E.C.; Alcazar-Corcoles, M.A.; Bouso, J.C. Ayahuasca and Public Health: Health Status, Psychosocial Well-Being, Lifestyle, and Coping Strategies in a Large Sample of Ritual Ayahuasca Users. J. Psychoact. Drugs 2019, 51, 135–145. [Google Scholar] [CrossRef] [PubMed]
- Renelli, M.; Fletcher, J.; Tupper, K.W.; Files, N.; Loizaga-Velder, A.; Lafrance, A. An exploratory study of experiences with conventional eating disorder treatment and ceremonial ayahuasca for the healing of eating disorders. Eat. Weight. Disord.-Stud. Anorexia Bulim. Obes. 2018, 25, 437–444. [Google Scholar] [CrossRef] [PubMed]
- Frecska, E.; Bokor, P.; Winkelman, M. The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization. Front. Pharmacol. 2016, 7, 35. [Google Scholar] [CrossRef] [PubMed]
- Kjellgren, A.; Eriksson, A.; Norlander, T. Experiences of encounters with ayahuasca—“the vine of the soul”. J. Psychoact. Drugs 2009, 41, 309–315. [Google Scholar] [CrossRef]
- St-Amour, S.; Hains-Monfette, G.; Dancause, K.N.; Cailhol, L.; Bernard, P. Antidepressant medication use and objectively measured physical activity and sedentary behaviors in adults: A cross-sectional analysis of a nationally representative sample of Canadian adults. Ment. Health Phys. Act. 2021, 20, 100394. [Google Scholar] [CrossRef]
- Read, J.; Williams, J. Adverse Effects of Antidepressants Reported by a Large International Cohort: Emotional Blunting, Suicidality, and Withdrawal Effects. Curr. Drug Saf. 2018, 13, 176–186. [Google Scholar] [CrossRef]
- ICEERS. Avoid Taking What Ayahuasca “Tells” You Literally; ICEERS: Catalonia, Spain, 2022. [Google Scholar]
- Girn, M.; Mills, C.; Roseman, L.; Carhart-Harris, R.L.; Christoff, K. Updating the dynamic framework of thought: Creativity and psychedelics. NeuroImage 2020, 213, 116726. [Google Scholar] [CrossRef] [PubMed]
- Taussig, M.T. Shamanism, Colonialism, and the Wild Man: A Study in Terror and Healing; The University of Chicago Press: Chicago, IL, USA, 1987. [Google Scholar]
- Watts, R.; Day, C.; Krzanowski, J.; Nutt, D.; Carhart-Harris, R. Patients’ accounts of increased “connectedness” and “acceptance” after psilocybin for treatment-resistant depression. J. Humanist. Psychol. 2017, 57, 520–564. [Google Scholar] [CrossRef]
- Carhart-Harris, R.; Bolstridge, M.; Rucker, J.; Day, C.M.J.; Erritzoe, D.; Kaelen, M.; Bloomfield, M.; Rickard, J.A.; Forbes, B.; Feilding, A.; et al. Psilocybin with psychological support for treatment-resistant depression: An open-label feasibility study. Lancet Psychiatry 2016, 3, 619–627. [Google Scholar] [CrossRef] [PubMed]
- Heuschkel, K.; Kuypers, K.P.C. Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review. Front. Psychiatry 2020, 11, 24. [Google Scholar] [CrossRef] [PubMed]
- Griffiths, R.R.; Hurwitz, E.S.; Davis, A.K.; Johnson, M.W.; Jesse, R. Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT. PLoS ONE 2019, 14, e0214377. [Google Scholar] [CrossRef]
- Davis, A.K.; Clifton, J.M.; Weaver, E.G.; Hurwitz, E.S.; Johnson, M.W.; Griffiths, R.R. Survey of entity encounter experiences occasioned by inhaled N,N-dimethyltryptamine: Phenomenology, interpretation, and enduring effects. J. Psychopharmacol. 2020, 13, 1008–1020. [Google Scholar] [CrossRef]
- Teixeira, P.J.; Johnson, M.W.; Timmermann, C.; Watts, R.; Erritzoe, D.; Douglass, H.; Kettner, H.; Carhart-Harris, R.L. Psychedelics and health behaviour change. J. Psychopharmacol. 2022, 36, 12–19. [Google Scholar] [CrossRef]
- Espinoza, Y. Sexual healing with Amazonian plant teachers: A heuristic inquiry of women’s spiritual–erotic awakenings. Sex. Relatsh. Ther. 2014, 29, 109. [Google Scholar] [CrossRef]
- Langley, C.; Armand, S.; Luo, Q.; Savulich, G.; Segerberg, T.; Sondergaard, A.; Pedersen, E.B.; Svart, N.; Overgaard-Hansen, O.; Johansen, A.; et al. Chronic escitalopram in healthy volunteers has specific effects on reinforcement sensitivity: A double-blind, placebo-controlled semi-randomised study. Neuropsychopharmacology 2023, 48, 664–670. [Google Scholar] [CrossRef]
Item | % (n) |
---|---|
Sex (n) | (8811) |
Female | 47.15 |
Male | 52.58 |
Other | 0.27 |
Age a (n) | (8781) |
Mean age (SD) | 40.65 years (12.20) |
University education (n) | (8827) |
Yes | 63.59 |
Current occupation (n) | (8768) |
Managers | 16.16 |
Professionals | 44.33 |
Technicians and trades workers | 8.46 |
Community and personal service workers | 11.28 |
Clerical and administrative workers | 7.85 |
Sales workers | 5.68 |
Machinery operators and drivers | 1.05 |
Labourers and related | 2.27 |
Never worked | 2.92 |
Marital or partnership status | (8750) |
Married | 37.69 |
Living with partner | 15.65 |
Divorced or separated | 9.05 |
Widowed | 0.85 |
Single | 27.62 |
Partnered, not living together | 9.14 |
Region of residence (n) | (8546) |
Brazil | 49.30 |
Other Latin American country | 5.31 |
Europe | 24.92 |
North America | 15.50 |
Australia and New Zealand | 4.24 |
Asia and Middle East | 0.73 |
Lifetime mental health diagnosis (n) | (8275) |
Yes | 37.39 |
Number of times drunk in life (n) | (8438) |
1 | 7.80 |
2–3 | 12.08 |
4–5 | 8.73 |
6–10 | 10.16 |
11–20 | 8.60 |
21–50 | 11.03 |
51–100 | 8.01 |
101–200 | 7.00 |
201–500 | 13.50 |
500+ | 13.08 |
Context of last use (n) | (8907) |
Ayahuasca church | 47.54 |
With a traditional shaman/guide | 20.61 |
Other contexts | 31.85 |
Life or Lifestyle Changes | Insights | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Childhood Events | Intimate Relationships | Family/ Personal Relationships | Own Personality | Ethics, Morals and Conduct | Life Purpose/Direction | Intellectual/Philosophical Topics | Body Function and Care | Connection of All Things | Natural World Connection | Plant Spirits/Guides | Sense of Sacredness/ Divine | Death and Dying | Social/Environmental Issues | Close to/Chosen by Spirit | No. of Correlations > 0.2 | |
Ending intimate relationship | 0.12 | 0.18 | 0.09 | 0.10 | 0.11 | 0.09 | 0.08 | 0.11 | 0.12 | 0.10 | 0.11 | 0.08 | 0.09 | 0.08 | 0.08 | 0 |
Starting intimate relationship | 0.15 | 0.20 | 0.15 | 0.13 | 0.16 | 0.16 | 0.12 | 0.17 | 0.11 | 0.05 | 0.11 | 0.14 | 0.14 | 0.15 | 0.09 | 1 |
Career/employment | 0.17 | 0.17 | 0.14 | 0.14 | 0.15 | 0.23 | 0.19 | 0.19 | 0.14 | 0.16 | 0.17 | 0.12 | 0.14 | 0.16 | 0.15 | 1 |
Starting own business | 0.13 | 0.13 | 0.11 | 0.10 | 0.12 | 0.16 | 0.13 | 0.15 | 0.08 | 0.08 | 0.11 | 0.10 | 0.11 | 0.11 | 0.13 | 0 |
Study in new area | 0.17 | 0.18 | 0.17 | 0.15 | 0.18 | 0.22 | 0.20 | 0.21 | 0.14 | 0.10 | 0.13 | 0.15 | 0.15 | 0.20 | 0.12 | 3 |
Healing personal rift | 0.26 | 0.26 | 0.24 | 0.18 | 0.18 | 0.18 | 0.15 | 0.20 | 0.16 | 0.14 | 0.15 | 0.14 | 0.15 | 0.16 | 0.12 | 4 |
New major personal rift | 0.05 | 0.08 | 0.08 | 0.05# | 0.06 | 0.04^ | 0.08 | 0.08 | 0.07 | 0.08 | 0.09 | 0.04^ | 0.06 | 0.05# | 0.09 | 0 |
New environmental/social causes | 0.18 | 0.17 | 0.19 | 0.15 | 0.27 | 0.23 | 0.21 | 0.24 | 0.16 | 0.15 | 0.17 | 0.21 | 0.19 | 0.45 | 0.11 | 6 |
Reduced environmental/social causes | 0.02^ | 0.03^ | 0.03^ | 0.00^ | 0.00^ | 0.03^ | 0.02^ | 0.04^ | 0.03^ | 0.05# | 0.04# | 0.01^ | 0.03^ | −0.02^ | 0.06 | 0 |
Place/city of residence | 0.12 | 0.12 | 0.12 | 0.09 | 0.11 | 0.15 | 0.13 | 0.14 | 0.12 | 0.13 | 0.14 | 0.10 | 0.10 | 0.11 | 0.12 | 0 |
Want/have a/another child | 0.16 | 0.15 | 0.16 | 0.13 | 0.20 | 0.16 | 0.11 | 0.16 | 0.10 | 0.01^ | 0.06 | 0.14 | 0.14 | 0.16 | 0.08 | 1 |
Not wanting a/another child | 0.03^ | 0.03^ | 0.00^ | 0.02^ | 0.01^ | 0.03^ | 0.05^ | 0.02^ | 0.05 | 0.06 | 0.06 | 0.01^ | 0.05# | 0.04# | 0.05 | 0 |
Reduced alcohol/drug abuse | 0.14 | 0.14 | 0.14 | 0.12 | 0.21 | 0.13 | 0.12 | 0.18 | 0.11 | 0.11 | 0.12 | 0.13 | 0.13 | 0.15 | 0.10 | 1 |
Increased alcohol/drug abuse | 0.01^ | 0.00^ | −0.01^ | 0.01^ | 0.02^ | 0.01^ | 0.01^ | 0.00^ | −0.02^ | 0.02^ | 0.03^ | −0.02^ | 0.01^ | 0.01^ | 0.04^ | 0 |
Abstaining from alcohol/drugs | 0.16 | 0.17 | 0.18 | 0.13 | 0.27 | 0.20 | 0.13 | 0.20 | 0.11 | −0.01^ | 0.05 | 0.20 | 0.19 | 0.22 | 0.04# | 5 |
Change in religious/spiritual status | 0.10 | 0.08 | 0.12 | 0.09 | 0.20 | 0.14 | 0.08 | 0.14 | 0.08 | 0.01^ | 0.04^ | 0.17 | 0.15 | 0.18 | 0.05 | 1 |
Caring for physical heath | 0.18 | 0.16 | 0.18 | 0.14 | 0.24 | 0.22 | 0.13 | 0.32 | 0.12 | 0.07^ | 0.11 | 0.19 | 0.16 | 0.26 | 0.10 | 4 |
Eating a healthy diet | 0.18# | 0.15 | 0.16 | 0.13 | 0.21 | 0.21 | 0.16 | 0.30 | 0.14 | 0.12 | 0.16 | 0.20 | 0.16 | 0.27 | 0.12 | 5 |
Eating meat | −0.04 | −0.08 | −0.02^ | −0.06 | −0.02^ | −0.04# | −0.08 | −0.10 | −0.09 | −0.16 | −0.12 | −0.05 | −0.05 | −0.11 | −0.08 | 0 |
Doing exercise | 0.10 | 0.09 | 0.10 | 0.08 | 0.16 | 0.15 | 0.08 | 0.20 | 0.06 | 0.01^ | 0.04^ | 0.10 | 0.08 | 0.19 | 0.03^ | 1 |
Time in nature | 0.17 | 0.11 | 0.15 | 0.12 | 0.22 | 0.21 | 0.12 | 0.22 | 0.13 | 0.14 | 0.17 | 0.18 | 0.16 | 0.27 | 0.12 | 4 |
Spiritual practices | 0.18 | 0.16 | 0.15 | 0.13 | 0.21 | 0.24 | 0.16 | 0.23 | 0.17 | 0.13 | 0.19 | 0.24 | 0.17 | 0.24 | 0.16 | 5 |
Creativity | 0.20 | 0.18 | 0.18 | 0.16 | 0.23 | 0.27 | 0.26 | 0.27 | 0.16 | 0.15 | 0.19 | 0.20 | 0.18 | 0.27 | 0.15 | 7 |
Comfort with sexuality | 0.19 | 0.20 | 0.15 | 0.13 | 0.18 | 0.21 | 0.15 | 0.25 | 0.10 | 0.11 | 0.15 | 0.15 | 0.18 | 0.21 | 0.13 | 4 |
No. of correlations > 0.2 | 2 | 3 | 1 | 0 | 10 | 10 | 3 | 11 | 0 | 0 | 0 | 5 | 0 | 9 | 0 |
Self-Insights (n = 6775) | External Insights (n = 6775) | |||
---|---|---|---|---|
B (SE) | p | B (SE) | p | |
Age (decades) | −0.23 (0.02) | 0.000 | −0.05 (0.02) | 0.011 |
University education | 0.23 (0.05) | 0.000 | 0.16 (0.05) | 0.001 |
Female | −0.1 (0.05) | 0.028 | −0.16 (0.05) | 0.001 |
LT mental health diagnoses a | 0.21 (0.02) | 0.000 | 0.14 (0.02) | 0.000 |
Number of times drunk | 0.21 (0.01) | 0.000 | 0.12 (0.01) | 0.000 |
PEQ-S | 0.3 (0.02) | 0.000 | 0.37 (0.02) | 0.000 |
SIMO | 0.03 (0.00) | 0.000 | 0.04 (0.00) | 0.000 |
Extreme fear | 0.00 (0.01) | 0.851 | 0.01 (0.01) | 0.430 |
Support and safety | −0.01 (0.04) | 0.786 | −0.01 (0.04) | 0.759 |
Preparation score | 0.19 (0.03) | 0.000 | 0.14 (0.03) | 0.000 |
Context—ayahuasca church b | −0.18 (0.08) | 0.020 | −0.69 (0.07) | 0.000 |
Context—other b | 0.17 (0.06) | 0.008 | 0.01 (0.06) | 0.841 |
Ayahuasca community | 0.24 (0.03) | 0.000 | 0.15 (0.03) | 0.000 |
Years since drunk | −0.02 (0.01) | 0.003 | 0.00 (0.01) | 0.476 |
Lifestyle Change (Model 1) (n = 6725) | Lifestyle Change (Model 2) (n = 6707) | |||
---|---|---|---|---|
B (SE) | p | B (SE) | p | |
Age (decades) | −0.04 (0.01) | 0.000 | −0.02 (0.01) | 0.000 |
University education | −0.04 (0.01) | 0.003 | −0.05 (0.01) | 0.000 |
Female | 0.05 (0.01) | 0.000 | 0.06 (0.01) | 0.000 |
LT mental health diagnoses a | 0.03 (0.01) | 0.000 | 0.01 (0.01) | 0.046 |
Number of times drunk | 0.05 (0.00) | 0.000 | 0.04 (0.00) | 0.000 |
PEQ-S | 0.06 (0.01) | 0.000 | 0.03 (0.01) | 0.000 |
SIMO | 0.01 (0.00) | 0.000 | 0.01 (0.00) | 0.000 |
Extreme fear | −0.01 (0.00) | 0.000 | −0.01 (0.00) | 0.000 |
Integration difficulties | −0.01 (0.00) | 0.000 | −0.01 (0.00) | 0.000 |
Support and safety | 0.02 (0.01) | 0.036 | 0.02 (0.01) | 0.035 |
Preparation score | 0.03 (0.01) | 0.000 | 0.01 (0.01) | 0.071 |
Context—ayahuasca church b | 0.02 (0.02) | 0.297 | 0.05 (0.02) | 0.011 |
Context—other b | 0.01 (0.02) | 0.505 | 0.00 (0.02) | 0.923 |
Ayahuasca community | 0.04 (0.01) | 0.000 | 0.02 (0.01) | 0.000 |
Years since drunk | 0.00 (0.00) | 0.572 | 0.00 (0.00) | 0.946 |
Insights—self | 0.05 (0.00) | 0.000 | ||
Insights—external | 0.03 (0.00) | 0.000 |
Ending Intimate Relationship | Starting Intimate Relationship | Career /Employment | Own Business | Study in New Area | Healing Personal Rift | New Personal Rift | New Environmental/Social Causes | Reduced Environmental/Social Causes | Place/City of Residence | Wanting/Having a/Another Child | Not Wanting a/another Child | Reduced Alcohol/Drug Abuse | Beginning Alcohol/Drug Abuse | Abstaining from Alcohol/Drugs | Religious/Spiritual Status Change | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% reporting change | 16.5 | 23.2 | 32.1 | 15.6 | 29.5 | 42.7 | 6.1 | 39.9 | 1.3 | 17.1 | 24.2 | 1.9 | 26.9 | 0.6 | 32.6 | 56.5 |
OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | |
Age (decades) | 0.87 (0.82; 0.92) *** | 0.77 (0.73; 0.81) *** | 0.93 (0.88; 0.97) ** | 1.01 (0.95; 1.07) | 0.88 (0.83; 0.92) *** | 0.92 (0.88; 0.97) ** | 0.86 (0.78; 0.95) ** | 0.90 (0.86; 0.94) *** | 0.92 (0.76; 1.12) | 0.97 (0.91; 1.03) | 0.60 (0.57; 0.64) *** | 0.92 (0.78; 1.08) | 0.85 (0.81; 0.90) *** | 0.76 (0.56; 1.02) | 0.89 (0.85; 0.94) *** | 0.96 (0.91; 1.01) |
University education | 1.11 (0.96; 1.27) | 1.28 (1.12; 1.46) *** | 1.08 (0.97; 1.21) | 0.87 (0.75; 1.00) | 1.00 (0.89; 1.12) | 1.01 (0.90; 1.12) | 0.97 (0.78; 1.19) | 1.09 (0.98; 1.23) | 0.86 (0.57; 1.32) | 1.05 (0.92; 1.21) | 1.53 (1.34; 1.75) *** | 0.84 (0.59; 1.19) | 0.89 (0.79; 1.00) | 0.65 (0.35; 1.19) | 0.90 (0.80; 1.01) | 0.96 (0.86; 1.08) |
Female | 1.55 (1.36; 1.77) *** | 0.80 (0.71; 0.91) *** | 0.84 (0.75; 0.94) ** | 0.82 (0.71; 0.95) ** | 0.97 (0.87; 1.09) | 1.27 (1.15; 1.42) *** | 1.14 (0.93; 1.39) | 0.94 (0.85; 1.05) | 0.88 (0.58; 1.33) | 1.17 (1.03; 1.33) * | 1.02 (0.90; 1.15) | 1.2 (0.85; 1.71) | 0.56 (0.50; 0.63) *** | 1.11 (0.6; 2.04) | 0.69 (0.62; 0.78) *** | 0.81 (0.73; 0.9) *** |
LT mental health diagnoses a | 1.01 (0.95; 1.06) | 1.09 (1.03; 1.14) ** | 1.10 (1.05; 1.15) *** | 1.02 (0.96; 1.08) | 1.07 (1.02; 1.12) ** | 1.14 (1.09; 1.19) *** | 1.21 (1.12; 1.29) *** | 1.04 (0.99; 1.09) | 1.19 (1.04; 1.36) * | 1.14 (1.08; 1.20) *** | 1.01 (0.96; 1.07) | 1.06 (0.94; 1.20) | 1.57 (1.50; 1.65) *** | 1.28 (1.07; 1.54) ** | 1.24 (1.18; 1.3) *** | 1.09 (1.04; 1.15) *** |
Number of times drunk | 1.08 (1.04; 1.12) *** | 1.18 (1.14; 1.22) *** | 1.10 (1.07; 1.14) *** | 1.12 (1.08; 1.17) *** | 1.10 (1.07; 1.14) *** | 0.99 (0.97; 1.02) | 1.00 (0.94; 1.05) | 1.12 (1.08; 1.15) *** | 0.99 (0.89; 1.11) | 1.14 (1.10; 1.18) *** | 1.19 (1.15; 1.23) *** | 0.94 (0.86; 1.03) | 1.06 (1.03; 1.10) *** | 1.00 (0.85; 1.18) | 1.20 (1.16; 1.23) *** | 1.18 (1.14; 1.21) *** |
PEQ-S | 1.00 (0.93; 1.07) | 1.03 (0.96; 1.10) | 1.07 (1.01; 1.13) * | 1.07 (0.99; 1.16) | 1.00 (0.94; 1.06) | 1.09 (1.03; 1.15) ** | 0.96 (0.86; 1.07) | 1.06 (1.00; 1.13) | 1.08 (0.86; 1.35) | 1.07 (1.00; 1.16) | 1.05 (0.98; 1.13) | 0.97 (0.8; 1.19) | 1.06 (0.99; 1.13) | 0.71 (0.54; 0.95) * | 1.11 (1.04; 1.18) ** | 1.37 (1.29; 1.45) *** |
SIMO | 1.00 (1.00; 1.01) | 1.00 (1.00; 1.00) | 1.01 (1.00; 1.01) ** | 1.01 (1.00; 1.01) ** | 1.00 (1.00; 1.01) | 1.00 (1.00; 1.01) | 0.99 (0.99; 1.00) | 1.00 (0.99; 1.00) | 0.99 (0.98; 1.00) | 1.01 (1; 1.01) ** | 1.00 (0.99; 1.00) | 1.00 (0.99; 1.02) | 1.00 (1.00; 1.00) | 1.00 (0.98; 1.02) | 1.00 (0.99; 1.00) | 1.01 (1; 1.01) ** |
Extreme fear | 1.03 (1.01; 1.06) ** | 0.99 (0.97; 1.01) | 1.01 (0.99; 1.03) | 1.00 (0.98; 1.03) | 0.99 (0.97; 1.01) | 1.00 (0.98; 1.02) | 1.04 (1.00; 1.07) * | 0.96 (0.94; 0.98) *** | 1.03 (0.97; 1.10) | 0.99 (0.97; 1.01) | 0.99 (0.97; 1.01) | 1.02 (0.96; 1.07) | 1.01 (0.99; 1.03) | 0.95 (0.86; 1.04) | 0.98 (0.96; 1.00) | 1.02 (1.00; 1.04) * |
Integration difficulties | 1.09 (1.06; 1.12) *** | 1.06 (1.03; 1.09) *** | 1.05 (1.02; 1.08) *** | 1.02 (0.99; 1.06) | 1.05 (1.02; 1.08) *** | 1.00 (0.98; 1.03) | 1.21 (1.16; 1.26) *** | 0.97 (0.94; 1.00) * | 1.18 (1.09; 1.28) *** | 1.10 (1.06; 1.13) *** | 1.01 (0.98; 1.05) | 1.11 (1.03; 1.19) ** | 1.01 (0.98; 1.04) | 1.25 (1.12; 1.40) *** | 0.98 (0.95; 1.01) | 1.01 (0.98; 1.04) |
Support and safety | 1.02 (0.90; 1.16) | 1.03 (0.91; 1.17) | 0.93 (0.84; 1.04) | 0.95 (0.83; 1.09) | 0.99 (0.88; 1.11) | 0.97 (0.88; 1.08) | 0.89 (0.74; 1.07) | 1.04 (0.93; 1.16) | 0.75 (0.54; 1.05) | 0.90 (0.8; 1.02) | 1.05 (0.92; 1.20) | 0.99 (0.75; 1.31) | 0.99 (0.88; 1.11) | 0.82 (0.53; 1.27) | 1.03 (0.91; 1.16) | 0.98 (0.88; 1.09) |
Preparation score | 0.96 (0.88; 1.04) | 1.01 (0.94; 1.09) | 1.13 (1.06; 1.21) *** | 1.02 (0.94; 1.11) | 1.05 (0.98; 1.12) | 1.08 (1.01; 1.15) * | 1.08 (0.95; 1.23) | 1.02 (0.96; 1.09) | 1.04 (0.79; 1.35) | 1.03 (0.95; 1.12) | 1.00 (0.93; 1.08) | 0.84 (0.68; 1.04) | 1.10 (1.02; 1.18) * | 0.8 (0.55; 1.16) | 1.14 (1.07; 1.23) *** | 0.96 (0.9; 1.02) |
Context—ayahuasca church b | 0.62 (0.49; 0.77) *** | 0.92 (0.74; 1.13) | 0.46 (0.38; 0.55) *** | 0.55 (0.43; 0.69) *** | 0.95 (0.79; 1.15) | 0.78 (0.66; 0.93) ** | 0.76 (0.54; 1.06) | 1.40 (1.16; 1.68) *** | 0.67 (0.33; 1.33) | 0.57 (0.46; 0.72) *** | 1.40 (1.13; 1.73) ** | 0.31 (0.16; 0.59) *** | 1.49 (1.22; 1.83) *** | 0.54 (0.2; 1.49) | 2.25 (1.85; 2.74) *** | 1.67 (1.39; 2) *** |
Context—other b | 1.00 (0.84; 1.20) | 0.81 (0.67; 0.97) * | 0.90 (0.77; 1.04) | 0.84 (0.69; 1.02) | 1.03 (0.88; 1.22) | 0.91 (0.79; 1.05) | 1.15 (0.88; 1.50) | 1.08 (0.92; 1.26) | 0.99 (0.59; 1.69) | 0.99 (0.82; 1.18) | 0.81 (0.67; 0.99) * | 1.1 (0.74; 1.64) | 1.30 (1.1; 1.54) ** | 0.68 (0.33; 1.44) | 0.98 (0.82; 1.17) | 1.19 (1.03; 1.39) * |
Ayahuasca community | 1.01 (0.93; 1.09) | 1.09 (1.01; 1.17) * | 0.98 (0.92; 1.04) | 1.06 (0.97; 1.14) | 1.06 (1.00; 1.14) | 1.00 (0.94; 1.07) | 1.02 (0.91; 1.14) | 1.07 (1.00; 1.14) * | 1.01 (0.81; 1.27) | 0.95 (0.88; 1.03) | 1.07 (0.99; 1.15) | 0.98 (0.82; 1.17) | 1.00 (0.94; 1.07) | 0.76 (0.55; 1.06) | 1.04 (0.97; 1.11) | 1.08 (1.01; 1.14) * |
Years since drunk | 1.01 (0.99; 1.03) | 1.03 (1.01; 1.04) ** | 1.02 (1.01; 1.04) ** | 1.00 (0.98; 1.02) | 1.01 (1.00; 1.03) | 0.99 (0.98; 1.01) | 1.01 (0.98; 1.04) | 1.01 (0.99; 1.02) | 1.01 (0.95; 1.08) | 1.03 (1.01; 1.05) *** | 1.01 (1.00; 1.03) | 1.04 (0.99; 1.09) | 0.97 (0.95; 0.99) ** | 1.05 (0.98; 1.13) | 0.98 (0.97; 1.00) | 0.99 (0.98; 1.01) |
Insights—self | 1.20 (1.14; 1.25) *** | 1.22 (1.17; 1.27) *** | 1.20 (1.16; 1.25) *** | 1.22 (1.16; 1.28) *** | 1.19 (1.15; 1.24) *** | 1.39 (1.34; 1.44) *** | 1.14 (1.06; 1.23) *** | 1.09 (1.05; 1.13) *** | 1.11 (0.97; 1.28) | 1.14 (1.08; 1.19) *** | 1.18 (1.13; 1.23) *** | 1.05 (0.94; 1.17) | 1.14 (1.1; 1.19) *** | 1.08 (0.89; 1.31) | 1.16 (1.12; 1.21) *** | 1.01 (0.97; 1.04) |
Insights—external | 1.04 (0.99; 1.08) | 1.06 (1.02; 1.10) ** | 1.09 (1.05; 1.13) *** | 1.06 (1.02; 1.12) * | 1.14 (1.1; 1.18) *** | 1.02 (0.99; 1.06) | 1.12 (1.04; 1.20) ** | 1.39 (1.34; 1.45) *** | 1.07 (0.93; 1.23) | 1.11 (1.06; 1.16) *** | 1.08 (1.04; 1.13) *** | 1.26 (1.11; 1.43) *** | 1.09 (1.05; 1.13) *** | 1.08 (0.88; 1.32) | 1.10 (1.05; 1.14) *** | 1.06 (1.02; 1.1) ** |
Overall Life Effect (n = 6502) | PWG (n = 6106) c | Kessler 10 d (n = 6492) | SF-12 (MCS) e (n = 6172) | |||||
---|---|---|---|---|---|---|---|---|
Beta (SE) | p | Beta (SE) | p | Beta (SE) | p | Beta (SE) | p | |
DEMOGRAPHIC | ||||||||
Age (decades) | −0.09 (0.04) | 0.000 | 0.12 (0.09) | 0.000 | ||||
Female | 0.03 (0.03) | 0.010 | 0.04 (0.10) | 0.000 | −0.05 (0.20) | 0.000 | ||
LT mental health diagnoses a | −0.04 (0.01) | 0.000 | 0.18 (0.04) | 0.000 | −0.14 (0.09) | 0.000 | ||
AYAHUASCA DRINKING | ||||||||
Times drunk | 0.12 (0.01) | 0.000 | 0.06 (0.04) | 0.000 | −0.04 (0.02) | 0.009 | 0.03 (0.05) | 0.085 |
PEQ-S | 0.13 (0.01) | 0.000 | 0.08 (0.09) | 0.000 | −0.06 (0.05) | 0.000 | ||
SIMO | 0.15 (0.00) | 0.000 | 0.12 (0.01) | 0.000 | 0.10 (0.01) | 0.000 | ||
Extreme fear | −0.07 (0.00) | 0.000 | −0.05 (0.03) | 0.000 | 0.06 (0.02) | 0.000 | −0.08 (0.03) | 0.000 |
Integration difficulties | −0.17 (0.01) | 0.000 | −0.08 (0.04) | 0.000 | 0.30 (0.03) | 0.000 | −0.26 (0.05) | 0.000 |
Support and safety | 0.03 (0.02) | 0.001 | 0.03 (0.15) | 0.002 | ||||
Context—ayahuasca church b | 0.00 (0.34) | 0.979 | ||||||
Context—other b | 0.00 (0.21) | 0.929 | −0.04 (0.28) | 0.006 | ||||
Ayahuasca community | 0.11 (0.02) | 0.000 | 0.07 (0.1) | 0.000 | −0.09 (0.06) | 0.000 | 0.11 (0.11) | 0.000 |
INSIGHTS | ||||||||
Family/personal relationships | 0.02 (0.03) | 0.033 | 0.04 (0.22) | 0.000 | ||||
Own personality | 0.03 (0.04) | 0.002 | ||||||
Ethics, morals and conduct | 0.02 (0.03) | 0.068 | ||||||
Life purpose/direction | 0.08 (0.03) | 0.000 | 0.09 (0.21) | 0.000 | −0.02 (0.12) | 0.074 | 0.03 (0.24) | 0.017 |
Sense of sacredness/divine | 0.02 (0.04) | 0.132 | 0.00 (0.25) | 0.870 | ||||
Death and dying | 0.01 (0.21) | 0.337 | ||||||
Close to/chosen by spirit | 0.02 (0.03) | 0.144 | 0.08 (0.20) | 0.000 | ||||
LIFE CHANGES | ||||||||
New personal rift | −0.03 (0.06) | 0.001 | 0.06 (0.21) | 0.000 | ||||
New environmental/social causes | 0.01 (0.19) | 0.354 | 0.00 (0.22) | 0.878 | ||||
Another child | 0.02 (0.03) | 0.068 | 0.02 (0.21) | 0.062 | ||||
Abstaining from alcohol or drugs | 0.03 (0.03) | 0.007 | 0.03 (0.20) | 0.008 | ||||
Religious/spiritual status | 0.03 (0.03) | 0.009 | 0.04 (0.19) | 0.000 | ||||
LIFESTYLE CHANGE | ||||||||
Caring for physical heath | 0.09 (0.02) | 0.000 | 0.11 (0.14) | 0.000 | −0.07 (0.08) | 0.000 | 0.07 (0.17) | 0.000 |
Eating a healthy diet | 0.06 (0.02) | 0.000 | 0.08 (0.15) | 0.000 | −0.03 (0.09) | 0.047 | 0.02 (0.17) | 0.144 |
Doing exercise | 0.03 (0.14) | 0.048 | ||||||
Time in nature | 0.03 (0.02) | 0.006 | 0.11 (0.13) | 0.000 | −0.03 (0.08) | 0.023 | 0.02 (0.16) | 0.242 |
Spiritual practices | 0.06 (0.02) | 0.000 | 0.09 (0.13) | 0.000 | −0.06 (0.08) | 0.000 | 0.04 (0.15) | 0.002 |
Creativity | 0.04 (0.02) | 0.001 | 0.11 (0.13) | 0.000 | −0.04 (0.08) | 0.003 | 0.05 (0.15) | 0.001 |
Comfort with sexuality | 0.08 (0.02) | 0.000 | 0.18 (0.11) | 0.000 | −0.06 (0.07) | 0.000 | 0.07 (0.13) | 0.000 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Perkins, D.; Opaleye, E.; Bouso, J.C.; Tófoli, L.F.; Sarris, J.; Schubert, V.; Ruffell, S.; Simonova, H. Insights, Life Changes and Lifestyle Changes Reported by Individuals Consuming Ayahuasca in Naturalistic Settings: Nature, Frequency and Associations with Mental Health and Wellbeing. Psychoactives 2023, 2, 256-286. https://doi.org/10.3390/psychoactives2040017
Perkins D, Opaleye E, Bouso JC, Tófoli LF, Sarris J, Schubert V, Ruffell S, Simonova H. Insights, Life Changes and Lifestyle Changes Reported by Individuals Consuming Ayahuasca in Naturalistic Settings: Nature, Frequency and Associations with Mental Health and Wellbeing. Psychoactives. 2023; 2(4):256-286. https://doi.org/10.3390/psychoactives2040017
Chicago/Turabian StylePerkins, Daniel, Emerita Opaleye, Jose Carlos Bouso, Luis Fernando Tófoli, Jerome Sarris, Violeta Schubert, Simon Ruffell, and Hana Simonova. 2023. "Insights, Life Changes and Lifestyle Changes Reported by Individuals Consuming Ayahuasca in Naturalistic Settings: Nature, Frequency and Associations with Mental Health and Wellbeing" Psychoactives 2, no. 4: 256-286. https://doi.org/10.3390/psychoactives2040017
APA StylePerkins, D., Opaleye, E., Bouso, J. C., Tófoli, L. F., Sarris, J., Schubert, V., Ruffell, S., & Simonova, H. (2023). Insights, Life Changes and Lifestyle Changes Reported by Individuals Consuming Ayahuasca in Naturalistic Settings: Nature, Frequency and Associations with Mental Health and Wellbeing. Psychoactives, 2(4), 256-286. https://doi.org/10.3390/psychoactives2040017